Nature Reviews Drug Discovery 2018-04-03

The gastroesophageal cancer drug market

Paul Wilcock, Rachel M. Webster

Index: 10.1038/nrd.2018.35

Full Text: HTML

Abstract

The gastroesophageal cancer drug market The gastroesophageal cancer drug market, Published online: 03 April 2018; doi:10.1038/nrd.2018.35Immune checkpoint inhibitors are forecast to expand the market for gastroesophageal cancer drugs, which is particularly large in Asia.

Latest Articles:

INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology

2018-04-06

[10.1038/nrd.2018.34]

Antivirals: Topical therapy for ocular herpes

2018-03-28

[10.1038/nrd.2018.47]

Infectious disease: Virus-based tuberculosis vaccine

2018-03-28

[10.1038/nrd.2018.50]

Immunotherapy: iPSC-based cancer vaccine

2018-03-28

[10.1038/nrd.2018.48]

George Yancopoulos

2018-03-28

[10.1038/nrd.2018.41]

More Articles...